Listing 1 - 9 of 9 |
Sort by
|
Choose an application
The theory of a stem-cell origin of cancer is neither ground breaking nor earth shattering. Many prominent investigators have established the foundation for this concept and performed the vital experiments to support its validity and merit. The purpose of this book is to illustrate how this theory may completely transform our current views and perspectives about cancer. It is anticipated that the variety of ramifications of a stem-cell origin of cancers will be embraced by the medical research community to bring new treatment modalities to the cancer patient. "The stem-cell theory of cancer has significant biologic and clinical consequences. Though components remain open to debate the fundamental observations are grounded in scientific experimentation. This text explains the conceptual aspects of cancer stem cells with an emphasis on the implications for our patients." - Steven T. Rosen, M.D. Series Editor .
Cancer -- Epidemiology. --- Cancer -- Etiology. --- Cancer -- Prevention. --- Cancer --- Stem cells --- Neoplasms --- Diseases --- Oncology --- Medicine --- Health & Biological Sciences --- Etiology --- Stem cells. --- Etiology. --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Medicine. --- Cancer research. --- Human genetics. --- Oncology. --- Medicine & Public Health. --- Cancer Research. --- Human Genetics. --- Cells
Choose an application
Prostate cancer is a life-altering diagnosis, not just for patients, but for their loved ones as well. Once, prostate cancer was most frequently diagnosed in men in their 60s and 70s; with increasing use of imaging modalities and PSA testing, the incidence is on the rise, and we are now seeing men in their 40s with the disease. This poses a challenge for clinical management depending on the stage of the disease—from watchful waiting or active surveillance to aggressive treatment with the risk of therapeutic nihilism. Despite being one of the most common cancers in Western men, its natural history, prognosis, and treatment are poorly understood. This book brings together a select faculty of experts to present a comprehensive view of the current state and future perspectives of prostate cancer. There are ten chapters in the book—the first four cover our present knowledge and understanding of the disease, the following three explore new advancements and treatments, particularly looking at overcoming resistance to therapy, and the remaining three chapters focus on specific molecules with the potential to become drug targets. We all have much to learn about prostate cancer. This book is aimed primarily at clinicians and scientists, but many areas will also be of interest to the layperson.
Prostate --- Cancer. --- Epidemiology of Prostate Cancer; Etiology of Prostate Cancer; Pathogenesis of Prostate Cancer; Current Diagnostics for Prostate Cancer; Combination Treatment for Prostate Cancer; Castration-Resistant Prostate Cancer; Theranostics in Metastatic Castrate Resistant Prostate Cancer; Adenocarcinoma of the Prostate; p53 in Prostate Cancer; MUCIN 1 in Prostate Cancer; STEAP Proteins in Prostate Cancer
Choose an application
Molecular Therapies of Cancer comprehensively covers the molecular mechanisms of anti-cancer drug actions in a comparably systematic fashion. While there is currently available a great deal of literature on anti-cancer drugs, books on the subject are often concoctions of invited review articles superficially connected to one another. There is a lack of comprehensive and systematic text on the topic of molecular therapies in cancer. A further deficit in the relevant literature is a progressive sub-specialization that typically limits textbooks on cancer drugs to cover either pharmacology or medicinal chemistry or signal transduction, rather than explaining molecular drug actions across all those areas; Molecular Therapies of Cancer fills this void. The book is divided into five sections: 1. Molecular Targeting of Cancer Cells; 2. Emerging and Alternative Treatment Modalities; 3. Molecular Targeting of Tumor-Host Interactions; 4. Anti-Cancer Drug Pharmacokinetics; and 5. Supportive Therapies.
Biomedicine. --- Cancer Research. --- Laboratory Medicine. --- Oncology. --- Medicine. --- Medical laboratories. --- Médecine --- Cancérologie --- Cancer -- Chemotherapy. --- Cancer -- Etiology. --- Cancer -- Genetic aspects. --- Cancer -- Molecular aspects. --- Molecular biology. --- Medicine --- Health & Biological Sciences --- Oncology --- Cancer --- Chemotherapy. --- Molecular aspects. --- Etiology. --- Genetic aspects. --- Cancer genetics --- Molecular biochemistry --- Molecular biophysics --- Cancer research. --- Laboratory medicine. --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Cancer genes --- Antineoplastic agents --- Treatment --- Oncology . --- Tumors --- Diagnosis, Laboratory --- Health facilities --- Laboratories --- Clinical medicine --- Clinical pathology --- Diagnostic laboratory tests --- Laboratory diagnosis --- Laboratory medicine --- Medical laboratory diagnosis --- Diagnosis --- Pathology --- Cancer research
Choose an application
Cancer is a major cause of human morbidity and mortality worldwide. Despite decades of basic and clinical research, the outcome for many cancer patients is still dismal. Although the existence of "stem-like" cells in cancer was hypothesized more than 150 years ago, recent discoveries have the potential to revolutionize cancer therapy. In particular, we now know that many cancers contain a fraction of self-renewing, drug- and radiation-resistant cells (cancer stem cells or cancer-initiating cells) and it is these cells—and not the major bulk of the tissue—that are the root cause for cancer initiation, relapse and metastasis. In a single volume, Stem Cells and Cancer offers up-to-date information about the role of stem cells in the development of normal and cancerous tissue, the mechanisms that differentiate normal from cancerous functions, and the use of these findings in developing mechanism-based therapies across all major types of cancer. It provides timely, cutting-edge information about cancer stem cells from the perspectives of both the basic and clinical sciences.
Cancer cells. --- Cancer --Etiology. --- Cancer --Treatment. --- Carcinogenesis. --- Cytology. --- Medicine. --- Oncology. --- Stem cells. --- Cancer cells --- Carcinogenesis --- Cancer --- Stem cells --- Cell Transformation, Neoplastic --- Stem Cells --- Neoplastic Stem Cells --- Neoplasms --- Diseases --- Neoplastic Processes --- Cells --- Pathologic Processes --- Anatomy --- Pathological Conditions, Signs and Symptoms --- Oncology --- Medicine --- Health & Biological Sciences --- Etiology --- Treatment --- Etiology. --- Treatment. --- Cancer therapy --- Cancer treatment --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Therapy --- Cancer research. --- Cell biology. --- Biomedicine. --- Cancer Research. --- Cell Biology. --- Pathology, Cellular --- Oncology . --- Tumors --- Cell biology --- Cellular biology --- Biology --- Cytologists --- Cancer research
Choose an application
Breast Cancer is the most common tumor in women and it is the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.
Breast -- Cancer -- Diagnosis. --- Breast -- Cancer -- Etiology. --- Breast -- Cancer -- Genetic aspects. --- Breast -- Cancer -- Treatment. --- Breast --- Breast Diseases --- Neoplasms by Site --- Neoplasms --- Skin Diseases --- Skin and Connective Tissue Diseases --- Diseases --- Breast Neoplasms --- Medicine --- Health & Biological Sciences --- Oncology --- Cancer --- Etiology --- Diagnosis --- Treatment --- Genetic aspects --- Diagnosis. --- Etiology. --- Genetic aspects. --- Treatment. --- Medicine. --- Oncology. --- Pathology. --- Surgical oncology. --- Medicine & Public Health. --- Surgical Oncology. --- Oncology . --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Tumors --- Excision
Choose an application
Significance of Stem Cells to Tumor Development Cancer stem cells remain a controversial topic and the criteria that define cancer stem cells are continuing to evolve. A recent surge in stem cell research has ignited a field of discovery into many human diseases including diabetes, neuropathologies, and cancer. By replacing specific differentiated cells that have either been lost or died, stem cell therapy proves to be a very promising approach to the treatment of many debilitating diseases. Though stem cells may provide therapeutic benefit under certain conditions, they are also often implicated in the initiation, progression, and therapeutic resistance of malignant disease. This first edition of Stem Cells and Cancer is intended to give a current perspective on the role of stem cells in cancer and strategies for novel therapies directed toward tumor stem cells. The current cancer stem cell hypothesis is presented in several chapters with distinctions made between the hierarchical and stochastic models of tumor cell development. "Stemness," self-renewal, pluripotency, clonality, and tumorigenicity are important concepts applied towards defining cancer stem cells. Signaling pathways such as Wnt, Sonic Hedgehog, Notch, and Bmi-1 that are involved in differentiation, proliferation, and survival are implicated in the malignant process. Additional chapters address the identification of cancer stem cell populations through the evaluation of molecular markers such as CD133, CD44, and CD24, for example, or by Hoescht dye exclusion to recognize ‘side populations.’ Mesenchymal and hematopoietic stem cells are described as well as mouse models that are employed to elucidate the properties and functionality of stem cells in cancer and the stem cell niche. This book encompasses a wide variety of human cancers that include but are not limited to leukemia, gliomas, breast, and prostate cancers. Resistance to conventional therapies, genetic versus epigenetic changes that affect therapeutic response and strategies to prevent disease recurrence are challenges have been incorporated into this volume. Stem Cells and Cancer represents a compendium of cutting edge research by experts in the field and will be instrumental in the study of this intriguing line of investigation for many years to come. Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research . Her current research focuses on stem cells, tumor vasculature, and target validation. Dr. Beverly A. Teicher is Vice President of Oncology Research at Genzyme Corporation. Dr. Teicher completed a PhD in Bioorganic Chemistry at the Johns Hopkins University and postdoctoral training at Yale University School of Medicine. Dr. Teicher joined Dana-Farber Cancer Institute as an Assistant Professor of Pathology and rose to Associate Professor of Medicine and Radiation Therapy, Harvard Medical School at Dana-Farber Cancer Institute and Joint Center for Radiation Therapy. Dr. Teicher is an active member of the international scientific community having authored or co-authored more than 400 scientific publications. She has edited eight books, is senior editor for the journal Clinical Cancer Research and is series editor for the Cancer Drug Discovery and Development book series.
Cancer cells. --- Cancer --Etiology. --- Stem cells. --- Stem cells --- Cancer cells --- Cancer --- Neoplastic Stem Cells --- Stem Cells --- Cells --- Anatomy --- Cytology --- Oncology --- Biology --- Medicine --- Health & Biological Sciences --- Etiology --- Etiology. --- Colony-forming units (Cells) --- Mother cells --- Progenitor cells --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Pathology, Cellular --- Oncology. --- Toxicology. --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Tumors --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Physiological effect
Choose an application
Over the years of cancer investigation a lot of discoveries in this field were made, and many associations between various biological carcinogens and cancer were revealed. Some of them are credibly determined, thus these infectious agents (human papilloma virus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, human herpes virus 8, human T-cell lymphotropic virus 1, human immunodeficiency virus, Merkel cell polyomavirus, Helicobacter pylori, Opisthorchis viverrini, Clonorchis sinensis, Schistosoma haematobium) are recognized as carcinogens and probable carcinogens by International Agency for Research on Cancer (IARC). The problem is of large importance, since share of infectious agents-related cancer cases is steadily increasing, reaching 25% according to certain estimates. It is worth noting that many of cancer cases are caused by infectious agents other than «conventional ones» like HPV, EBV, HBV, HCV, H.pylori etc. In recent years, a number of significant breakthroughs in the field were performed, such as the discovery of the microbiota role in cancer causation. Here in this book, almost all connections between «unconventional» carcinogenic infectious agents and cancer are described and analyzed comprehensively. The monograph was written with the idea that the language and concept will be rather simple and understandable for the wide audience, but the information contained in the book will be useful even for researchers working in the field of biological carcinogenesis who are familiar with the problem. Infectious Agents and Cancer may also be helpful for PhD, graduate and undergraduate students of biomedical faculties, and for their lecturers as well. The main idea of this book is to attract the attention to the problem of infectious agents causing human cancer other than the known biological carcinogens. .
Cancer -- Etiology. --- Cancer -- Immunological aspects. --- Chronic diseases -- Etiology. --- Medicine. --- Cancer --- Diseases --- Neoplasms --- Medicine --- Health & Biological Sciences --- Oncology --- Etiology --- Tumors. --- Virus diseases. --- Bacterial diseases. --- Infection. --- Etiology. --- Infectious diseases --- Bacterial infections --- Viral diseases --- Viral infections --- Virus infections --- Tumours --- Cancer research. --- Microbiology. --- Bacteriology. --- Biomedicine. --- Cancer Research. --- Biomedicine general. --- Medical microbiology --- Communicable diseases --- Medical bacteriology --- Pathogenic bacteria --- Medical virology --- Pathogenic viruses --- Pathology --- Cysts (Pathology) --- Causes and theories of causation --- Oncology. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Physicians --- Microbiology --- Microbial biology --- Biology --- Microorganisms --- Tumors --- Health Workforce --- Biomedicine, general. --- Cancer research
Choose an application
HPV infections and their clinical consequences are a major disease burden. This book aims to provide an updated comprehensive summary of the available data in this multidisciplinary field. The different contributing experts, using the most recent information, provide updated in depth reviews on different aspects of HPV infections. The reader will discover how quickly interesting new data has been generated, not only on the immune-biology of this infection, but also on the more clinical aspects like the diagnostic approaches and techniques, the success of primary and secondary prevention, the follow-up in vaccinated cohorts or individuals, and the various treatment options. “[Dr. Franco Borruto]… has focused on the prevention of carcinoma of the cervix and, in particular, HPV vaccination, divulgating in different parts of the world its use in young women. And the result of this enormous labour is this magnificent book, presented here today, edited together with Prof. Marc De Ridder, a famous immunologist of world-wide renown that work in Brussels, Belgium. This work, this book, has involved the collaboration of the world’s leading experts on the issue. I am sure that, in the field of the carcinoma of the cervix prevention, this book will mark a fundamental milestone.” —Prof. José M. Carrera, President of Matres Mundi, Secretary General of International Academy of Perinatal Medicine.
Cervix uteri -- Cancer -- Etiology. --- Generative organs -- Infections. --- Medicine. --- Oncology. --- Papillomavirus diseases. --- Toxicology. --- Papillomavirus diseases --- Cervix uteri --- Papillomaviruses --- Genital warts --- DNA Virus Infections --- Uterine Neoplasms --- Tumor Virus Infections --- Uterine Cervical Diseases --- Uterine Diseases --- Virus Diseases --- Genital Neoplasms, Female --- Urogenital Neoplasms --- Genital Diseases, Female --- Diseases --- Female Urogenital Diseases --- Neoplasms by Site --- Female Urogenital Diseases and Pregnancy Complications --- Neoplasms --- Uterine Cervical Neoplasms --- Papillomavirus Infections --- Biology --- Medicine --- Health & Biological Sciences --- Infectious Diseases --- Microbiology & Immunology --- Oncology --- Cancer --- Etiology --- Health aspects --- Papillomaviruses. --- Cancer. --- Cervical cancer --- HPV (Virus) --- Human papilloma virus --- Human wart virus --- Infectious human wart virus --- Papilloma viruses --- Papillomaviridae --- Papillomavirus --- Papovaviruses --- Wart virus --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Oncogenic DNA viruses --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Tumors --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Physiological effect
Choose an application
The Rho GTPases in Cancer is the first volume to collect and summarize the current understanding of the Rho GTPases and their involvement in the progression of human cancer. The critical role of the Rho GTPases, their regulatory proteins, and their effectors in cancer progression has become increasingly evident over the past decade. As translational research increases on these proteins, their importance as keystone molecules in vital cellular process is highlighted. Thus, these molecules represent a major class of potential therapeutic targets that could be exploited clinically. This aspect of Rho GTPase biology is developing, therefore the contents of The Rho GTPases in Cancer should prove of interest to clinicians and members of the cancer research community wishing to develop new treatments for cancer.
Cancer -- Etiology. --- Rho GTPases --- Cancer --- Monomeric GTP-Binding Proteins --- Diseases --- rho GTP-Binding Proteins --- Neoplasms --- GTP-Binding Proteins --- Intracellular Signaling Peptides and Proteins --- GTP Phosphohydrolases --- Peptides --- Proteins --- Carrier Proteins --- Amino Acids, Peptides, and Proteins --- Acid Anhydride Hydrolases --- Chemicals and Drugs --- Hydrolases --- Enzymes --- Enzymes and Coenzymes --- Medicine --- Human Anatomy & Physiology --- Oncology --- Animal Biochemistry --- Health & Biological Sciences --- Etiology --- Rho GTPases. --- G proteins. --- GTP-binding proteins --- GTP regulatory proteins --- Guanine nucleotide-binding proteins --- Guanine nucleotide regulatory proteins --- Rho G proteins --- Rho GTP-binding proteins --- Medicine. --- Cancer research. --- Pharmacology. --- Cell biology. --- Biomedicine. --- Cancer Research. --- Cell Biology. --- Pharmacology/Toxicology. --- Membrane proteins --- G proteins --- Guanosine triphosphatase --- Oncology. --- Cytology. --- Toxicology. --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Tumors --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Physiological effect
Listing 1 - 9 of 9 |
Sort by
|